Glenmark Pharmaceuticals Ltd has reported a 16% rise in consolidated net profit for the third quarter ended December to Rs 403 crore, the drugmaker said in an after-market statement on Friday. Consolidated revenue rose 15% year-on-year to Rs 3,900 crore during the period.The strong quarterly performance was primarily driven by robust growth in the Indian […]
